Scientists trace out intricate molecular pathway that may explain tamoxifen resistanc

[News]

For reasons unknown, many patients with breast cancer treated with the estrogen receptor-blocking drug tamoxifen eventually become resistant to the treatment despite the fact that their cancer cells still have the estrogen receptor proteins that the drug normally targets.

More... (http://www.news-medical.net/news/20150924/Scientists-trace-out-intricate-molecular-pathway-that-may-explain-tamoxifen-resistance-in-breast-cancer-patients.aspx)